What Are the Benefits of AviClear for Acne?

Many people assume that once they’ve reach adulthood, they’ll no longer have to deal with uncomfortable flare-ups of acne. New Jersey’s South Jersey Skin Care & Laser Center team explains that unfortunately, acne can still be a problem for many adults during their 20s, 30s, and older.

Acne is a common skin condition that around 50 million American teens and young adults suffer from each year. It is caused by a combination of factors including excess oil production, pores being blocked with oil and dead skin, bacteria, and inflammation. It usually develops on the face, forehead, chest, upper back, and shoulders because these are the areas where the skin has the highest number of oil glands. Hormonal changes, stress, and certain medications can trigger breakouts of acne or make them worse.

There is no single acne treatment that works for everyone. Common acne treatments might work well for one person, but not be very effective for some patients. Topical products will usually only produce temporary results, and oral medications can present challenges, such as harsh side effects. Skin tone, age, and other medical conditions may disqualify many people from being a candidate for certain acne treatments.

Patients looking for an alternative to traditional topical creams, pills, and chemical peels may consider AviClear, a laser-based treatment that targets the underlying source of acne—the sebaceous glands in the skin—without the need for prescription medications. The 1726 nm wavelength laser light that AviClear gives off selectively targets and supresses active sebaceous glands to prevent the production of sebum, which is the waxy, oily substance produced to protect and hydrate the skin.

AviClear is the first and only energy-based device to be approved by the FDA for the treatment of mild, moderate, and severe acne. It’s also approved for all skin types. See below for some of the main benefits of targeted laser light in treating this common skin condition:

It Reduces Acne Breakouts

Studies show that in addition to clearing up existing breakouts, AviClear also helps to reduce future flare-ups. The treatment makes acne breakouts shorter, less intense, and less frequent.

Results Continue to Improve

The acne-reducing results from AviClear continue to get better over time, making it one of the best long-term options for acne treatment. Previous devices that were designed for acne did not yield very effective or long-lasting results. The AviClear treatment is completed in three 30-minute sessions performed once per month for three consecutive months. Patients will notice immediate results after these three sessions. Some data suggests that the results will last for up to nine months.

No Recovery Time Is Needed

Another advantage of AviClear is that there’s no downtime required after, and patients can resume their normal activities right away. Not much aftercare or maintenance is required, either. Just be sure to wear sunscreen after a treatment and avoid applying occlusive agents to your skin, such as Vaseline.

Almost Anyone Can Be a Candidate

As opposed to many other laser skin treatments, an appealing factor about AviClear is that almost anyone can be a good candidate for the approach. It does not target or adversely affect the melanin in darker skin tones and won’t cause pigmentation issues. The laser energy is only absorbed by the sebaceous glands. AviClear is effective for patients in any age group. It can be ideal for patients who have tried oral medications and would like a less-invasive method to treat persistent acne. Although it is approved for mild acne as well, AviClear typically yields the best results for patients who have moderate to severe acne and have been taking chronic oral medications.

Want to learn more about how AviClear can help reduce acne, as well as other information about the condition and its treatments? New Jersey’s South Jersey Skin Care & Laser Center team can provide answers. Call (856) 810-9888 or fill out a contact form to schedule a consultation.